Guardant Health Tops Business Insider's Innovative Biotech List — Guardant Health, Inc.

Event summary

Guardant Health named to Business Insider’s America's Most Innovative Businesses 2027 list, earning five-star recognition among 13 biotech firms.
Company highlighted for R&D investment, patent growth, and industry perception over the past five years.
Key milestones include delivering 1 million patient tests and launching Shield, the FDA-approved blood test for colorectal cancer screening.
Guardant360 Liquid CDx integrates genomic and epigenomic data for comprehensive cancer insights.
Shield Multi-Cancer Detection (MCD) launched in Asia, expanding global commercial access.

The big picture

Guardant Health’s recognition underscores the growing importance of liquid biopsy technologies in precision oncology. The company’s ability to translate sustained R&D investment into FDA-approved products positions it as a leader in cancer detection and treatment selection. Its focus on AI-driven diagnostics and global expansion reflects broader industry trends toward personalized medicine and digital health innovation.

What we're watching

Market Expansion: The pace at which Guardant Health can scale Shield Multi-Cancer Detection (MCD) in Asia and other global markets.
Regulatory Approvals: Whether Guardant360 Liquid CDx can secure additional companion diagnostic approvals to expand its clinical utility.
AI Integration: How InfinityAI’s multiomic technology platform will enhance real-world evidence for biopharmaceutical research and regulatory decision-making.